The journal of nutrition, health & aging

, Volume 16, Issue 9, pp 743–748 | Cite as

The protective effect of calcium on bone mass in postmenopausal women with high selenium intake

  • J. D. Pedrera-Zamorano
  • J. F. Calderon-García
  • R. Roncero-Martin
  • P. Mañas-Nuñez
  • J. M. Moran
  • J. M. Lavado-Garcia



Nutritional factors, especially the two essential nutrients calcium and vitamin D, have been shown to play an important role in bone health. We wanted to determine the possible protective effect of calcium intake in adequate amounts on bone mass as assessed by quantitative ultrasound in postmenopausal women who also have a high intake of selenium.


Health district of Cáceres, Spain.

Participants and Study Design

335 postmenopausal women aged 60.9 (SD = 8.1) years. Women were stratified based on the vitamin D, vitamin E, calcium intake and the calcium/protein and calcium/phosphorous index.


Bone status (Ad-SoS measured at the phalanges) was assessed with an ultrasound device model DBM Sonic 1200R. Food intake was quantified using dietetic scales, measuring cups, and spoons based on 7 days of diet records. Urine samples were collected the morning of testing after an overnight fast. Venous blood samples for the hematological and biochemical studies were also obtained in the fasting state.


In the group of women with Ca intake < 800 mg / d we found a significant and negative relationship between Ad-SoS with age (β = −4.020, F = 23.327) and selenium intake (β = −0.419, F = 10.067), as well as a positive relationship with Ca intake (β = 0.104 and F = 7.084) (p <0.0001 in all). In the group of women with Ca intake > 800 mg / d, age has a significant and negative relationship (β = −4.829 and F = 106.745), whereas folic acid intake has a significant and positive relationship (β = 0.047 and F = 5.858) (p <0.0001 in both).


Elevated selenium intake negatively affects bone mass measurements in postmenopausal women over the age of 51 but only if calcium intake is also less than 800 mg / day. When calcium intake is greater than 800 mg/day, selenium did not appear to affect bone mass.

Key words

Ad-SoS ultrasound bone calcium selenium 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Becker C. Pathophysiology and clinical manifestations of osteoporosis. Clin Cornerstone 2008; 9:42–47.PubMedCrossRefGoogle Scholar
  2. 2.
    Rolland Y, Abellan van KG, Benetos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashemi F, Orcel P, Piette F, Ribot C, Rifcz P, Roux C, Taillandier J, Tremollieres F, Weryha G, Vellas B. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging 2008; 12:335–346.PubMedCrossRefGoogle Scholar
  3. 3.
    Czernichow S, Fan T, Nocea G, Sen SS. Calcium and vitamin D intake by postmenopausal women with osteoporosis in France. Curr Med Res Opin 2010; 26:1667–1674.PubMedCrossRefGoogle Scholar
  4. 4.
    Quesada Gomez JM, Blanch RJ, Diaz CM, Diez PA. Calcium citrate and vitamin D in the treatment of osteoporosis. Clin Drug Investig 2011; 31:285–298.PubMedGoogle Scholar
  5. 5.
    Sunyecz JA. The use of calcium and vitamin D in the management of osteoporosis. TherClin RiskManag 2008; 4:827–836.Google Scholar
  6. 6.
    Chailurkit LO, Saetung S, Thakkinstian A, Ongphiphadhanakul B, Rajatanavin R. Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin Endocrinol (Oxf) 2010; 73:167–172.Google Scholar
  7. 7.
    Karkkainen M, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, Honkanen R, Jurvelin J, Alhava E, Kroger H. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65–71 years: a 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos Lit 2010; 21:2047–2055.CrossRefGoogle Scholar
  8. 8.
    Dawson-Hughes B, Dallai GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323:878–883.PubMedCrossRefGoogle Scholar
  9. 9.
    Bonjour JP, Gueguen L, Palacios C, Shearer MJ, Weaver CM. Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr 2009; 101:1581–1596.PubMedCrossRefGoogle Scholar
  10. 10.
    Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr 2006; 46:621–628.PubMedCrossRefGoogle Scholar
  11. 11.
    Yamaguchi M, Uchiyama M. Preventive effect of zinc for toxic actions of germanium and selenium on bone metabolism in weanling rats. Res Exp Med (Bed) 1987; 187:395–400.CrossRefGoogle Scholar
  12. 12.
    Guglielmi G, Scalzo G, de TF, Peh WC. Quantitative ultrasound in osteoporosis and bone metabolism pathologies. Radiol Clin North Am 2010; 48:577–588.PubMedCrossRefGoogle Scholar
  13. 13.
    Rico H, Canal ML, Manas P, Lavado JM, Costa C, Pedrera JD. Effects of caffeine, vitamin D, and other nutrients on quantitative phalangeal bone ultrasound in postmenopausal women. Nutrition 2002; 18:189–193.PubMedCrossRefGoogle Scholar
  14. 14.
    Pedrera JD, Canal ML, Postigo S, Lavado J, Hernandez ER, Rico H. Phalangeal bone ultrasound and its possible correlation with nutrient in an area of high protein intake. Ann Nutr Metab 2001; 45:86–90.PubMedCrossRefGoogle Scholar
  15. 15.
    Pedrera-Zamorano JD, Lavado-Garcia JM, Roncero-Martin R, Calderon-Garcia JF, Rodriguez-Dominguez T, Canal-Macias ML. Effect of beer drinking on ultrasound bone mass in women. Nutrition 2009; 25:1057–1063.PubMedCrossRefGoogle Scholar
  16. 16.
    Hans D, Krieg MA. The clinical use of quantitative ultrasound (QUS) in the detection and management of osteoporosis. IEEE Trans Ultrason Ferroelectr Freq Control 2008; 55:1529–1538.PubMedCrossRefGoogle Scholar
  17. 17.
    Malavolta N, Mule R, Frigato M. Quantitative ultrasound assessment of bone. Aging Clin Exp Res 2004; 16Suppl:23–28.PubMedGoogle Scholar
  18. 18.
    Ha EJ, Smith AM. Selenium-dependent glutathione peroxidase activity is increased in healthy post-menopausal women. Biol Trace Elem Res 2009; 131:90–95.PubMedCrossRefGoogle Scholar
  19. 19.
    Pizent A, Pavlovic M, Jurasovic J, Dodig S, Pasalic D, Mujagic R. Antioxidants, trace elements and metabolic syndrome in elderly subjects. J Nutr Health Aging 2010; 14:866–871.PubMedCrossRefGoogle Scholar
  20. 20.
    Mackinnon ES, Rao AV, Rao LG. Dietary restriction of lycopene for a period of one month resulted in significantly increased biomarkers of oxidative stress and bone resorption in postmenopausal women. J Nutr Health Aging 2011; 15:133–138.PubMedCrossRefGoogle Scholar
  21. 21.
    Berr C, Akbaraly T, Amaud J, Hininger I, Roussel AM, Barberger GP. Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids. J Nutr Health Aging 2009; 13:14–18.PubMedCrossRefGoogle Scholar
  22. 22.
    Navarro-Alarcon M, Cabrera-Vique C. Selenium in food and the human body: a review. Sci Total Environ 2008; 400:115–141.PubMedCrossRefGoogle Scholar
  23. 23.
    Foster LH, Sumar S. Selenium in health and disease: a review. Crit Rev Food Sci Nutr 1997; 37:211–228.PubMedCrossRefGoogle Scholar
  24. 24.
    Tinggi U. Essentiality and toxicity of selenium and its status in Australia: a review. Toxicol Lett 2003; 137:103–110.PubMedCrossRefGoogle Scholar
  25. 25.
    Zachara BA, Pawluk H, Bloch-Boguslawska E, Sliwka KM, Korenkiewicz J, Skok Z, Rye K. Tissue level, distribution, and total body selenium content in healthy and diseased humans in Poland. Arch Environ Health 2001; 56:461–466.PubMedCrossRefGoogle Scholar
  26. 26.
    Hiraoka K, Komiya S, Hamada T, Zenmyo M, Inoue A. Osteosarcoma cell apoptosis induced by selenium. J Orthop Res 2001; 19:809–814.PubMedCrossRefGoogle Scholar
  27. 27.
    Jakob F, Becker K, Paar E, Ebert-Duemig R, Schutze N. Expression and regulation of thioredoxin reductases and other selenoproteins in bone. Methods Enzymol 2002; 347:168–179.PubMedCrossRefGoogle Scholar
  28. 28.
    Brozmanova J, Manikova D, Vlckova V, Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol 2010; 84:919–938.PubMedCrossRefGoogle Scholar
  29. 29.
    Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, Hurst R. Selenium in human health and disease. Antioxid Redox Signal 2011; 14:1337–1383.PubMedCrossRefGoogle Scholar
  30. 30.
    Moreno-Reyes R, Egrise D, Neve J, Pasteels JL, Schoutens A. Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res 2001; 16:1556–1563.PubMedCrossRefGoogle Scholar
  31. 31.
    Ren FL, Guo X, Zhang RI, Wang S, Zuo H, Zhang ZT, Geng D, Yu Y, Su M. Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats. Osteoarthritis Cartilage 2007; 15:1171–1177.PubMedCrossRefGoogle Scholar
  32. 32.
    Ozdemir S, Ayaz M, Can B, Turan B. Effect of selenite treatment on ultrastructural changes in experimental diabetic rat bones. Biol Trace Elem Res 2005; 107:167–179.PubMedCrossRefGoogle Scholar
  33. 33.
    Turan B, Bayari S, Balcik C, Severcan F, Akkas N. A biomechanical and spectroscopic study of bone from rats with selenium deficiency and toxicity. Biometals 2000; 13:113–121.PubMedCrossRefGoogle Scholar
  34. 34.
    Turan B, Can B, Delilbasi E. Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis. Clin Rheumatol 2003; 22:432–436.PubMedCrossRefGoogle Scholar
  35. 35.
    Bureau I, Anderson RA, Arnaud J, Raysiguier Y, Favier AE, Roussel AM. Trace mineral status in post menopausal women: impact of hormonal replacement therapy. J Trace Elem Med Biol 2002; 16:9–13.PubMedCrossRefGoogle Scholar
  36. 36.
    Gur A, Colpan L, Nas K, Cevik R, Sarac J, Erdogan F, Duz MZ. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab 2002; 20:39–43.PubMedCrossRefGoogle Scholar

Copyright information

© Serdi and Springer-Verlag France 2012

Authors and Affiliations

  • J. D. Pedrera-Zamorano
    • 1
    • 2
  • J. F. Calderon-García
    • 1
  • R. Roncero-Martin
    • 1
  • P. Mañas-Nuñez
    • 1
  • J. M. Moran
    • 1
  • J. M. Lavado-Garcia
    • 1
  1. 1.Metabolic Bone Diseases Research GroupUniversity of Extremadura, Nursing SchoolCaceresSpain
  2. 2.GIEMO, Department of NursingUniversity of ExtremaduraCáceresSpain

Personalised recommendations